Source Feed: The Globe and Mail
Author: Kelly Grant
Publication Date: October 26, 2025 - 21:08
Health Canada approves drug that slows progression of Alzheimer’s disease
October 26, 2025
Health Canada has for the first time approved a disease-modifying drug for Alzheimer’s disease, a watershed moment that offers hope for patients but does not guarantee that the complex and expensive intravenous therapy will be widely available in this country.
The federal regulator on Friday granted a conditional authorization for lecanemab, an antibody drug that can slow the progression of the disease for some people with mild cognitive impairment or early-stage dementia owing to Alzheimer’s.
Unpublished Newswire
A Quebec program is being described as the only one of its kind in the country: a treatment centre that allows mothers to keep their children with them while they recover.
November 21, 2025 - 18:43 | Alessia Simona Maratta | Global News - Canada
The Canadian Union of Postal Employees said Friday it will agree to pause strike action and enter final negotiations once the new deals are signed.
November 21, 2025 - 18:43 | Sean Boynton | Global News - Canada
The moment Ryan Wedding’s life pivoted from one kind of white powder to another can be traced to the chilly slopes of Salt Lake City, on Feb. 14, 2002. The 20-year-old Canadian snowboarder was already being discussed as a superstar in the making, and was now preparing for his first Olympic qualifying run in the parallel giant slalom.He had been groomed from a young age for this chance, after growing up near Thunder Bay in a family that ran the Mount Baldy ski club, with multiple competitive skiers in its ranks. Mr. Wedding had joined Team Canada at the age of 15 and raced around the...
November 21, 2025 - 18:36 | Eric Andrew-Gee | The Globe and Mail
Comments
Be the first to comment